Axsome Therapeutics (AXSM) PT Raised to $80 at Guggenheim
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Price: $144.43 --0%
Rating Summary:
27 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 8
Rating Summary:
27 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 8
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $80.00 (from $72.00) while maintaining a Buy rating.
You May Also Be Interested In
- Axsome Therapeutics (AXSM) PT Lowered to $284 at Mizuho
- Carter's (CRI) PT Lowered to $28 at BofA Securities
- Citi cuts Arthur J. Gallagher rating to Neutral, lifts target
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
